<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03880747</url>
  </required_header>
  <id_info>
    <org_study_id>SNUBHGS_VNP</org_study_id>
    <nct_id>NCT03880747</nct_id>
  </id_info>
  <brief_title>Dumping Syndrome and Quality of Life After Vagus Nerve-preserving Distal Gastrectomy</brief_title>
  <acronym>VNP</acronym>
  <official_title>Incidence of Dumping Syndrome After Laparoscopic Vagus Nerve-preserving Distal Gastrectomy for Early Gastric Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Bundang Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is no consensus on what type of function-preserving gastrectomy can provide the best
      patient quality of life (QOL). This study aims to evaluate the incidence of dumping syndrome
      after vagus nerve-preserving distal gastrectomy (VPNDG).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is designed as a prospective observational phase II study with a follow-up period
      of 12 months. Patients diagnosed with early gastric cancer in the distal 2/3rd of the stomach
      who are planned to undergo laparoscopic VPNDG with Roux-en Y gastrojejunostomy will be
      enrolled. Primary endpoint is incidence of dumping syndrome defined by Sigstad score 7 after
      a 3-month interval. Other outcomes include operative data, early complication, and patient
      QOL using the European Organization for Research and Treatment of Cancer C-30 and STO22
      modules.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 9, 2017</start_date>
  <completion_date type="Anticipated">June 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Dumping syndrome</measure>
    <time_frame>1 year</time_frame>
    <description>Sigstad score of equal or more than 7</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>EORTC C-30/STO22</measure>
    <time_frame>3 months, 6 months, 1 year</time_frame>
    <description>Quality of life surveys</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative complication</measure>
    <time_frame>3 months, 6 months, 1 year</time_frame>
    <description>incidence of postoperative complication</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of gallstones</measure>
    <time_frame>1 year</time_frame>
    <description>Found in follow-up CT or ultrasound</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Operative time</measure>
    <time_frame>Immediately after operation</time_frame>
    <description>Time of operation</description>
  </other_outcome>
  <other_outcome>
    <measure>Estimated blood loss</measure>
    <time_frame>Immediately after operation</time_frame>
    <description>Blood loss during operation</description>
  </other_outcome>
  <other_outcome>
    <measure>Time to first flatus</measure>
    <time_frame>Within 1 week</time_frame>
    <description>Postoperative day to first flatus</description>
  </other_outcome>
  <other_outcome>
    <measure>Hospital stay</measure>
    <time_frame>Within 1 week</time_frame>
    <description>Total hospital stay</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Stomach Neoplasm</condition>
  <arm_group>
    <arm_group_label>Vagus nerve preserving group</arm_group_label>
    <description>Patients who underwent vagus nerve-preserving distal gastrectomy for early gastric cancer</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Vagus nerve-preserving distal gastrectomy</intervention_name>
    <description>Laparoscopic distal gastrectomy with the preservation of the celiac and hepatic branch of the vagus nerve.</description>
    <arm_group_label>Vagus nerve preserving group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients diagnosed with early gastric cancer in the distal 2/3rd of the stomach
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients diagnosed with early gastric cancer in the distal 2/3rd of the stomach
             planned to undergo laparoscopic vagus nerve-preserving distal gastrectomy

        Exclusion Criteria:

          -  Sacrificed vagus nerve

          -  Anastomosis other than Roux-en Y gastrojejunostomy or uncut Roux-en Y
             gastrojejunostomy

          -  conversion to an open procedure

          -  combined resection of other organs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hyung-Ho Kim, PhD</last_name>
    <phone>+82-31-787-7099</phone>
    <email>hhkim@snubh.org,</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam</city>
        <state>Gyeonggi-do</state>
        <zip>13620</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hyung-Ho Kim, PhD</last_name>
      <phone>+82-31-787-7099</phone>
      <email>hhkim@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 17, 2019</study_first_submitted>
  <study_first_submitted_qc>March 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 19, 2019</study_first_posted>
  <last_update_submitted>March 17, 2019</last_update_submitted>
  <last_update_submitted_qc>March 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Bundang Hospital</investigator_affiliation>
    <investigator_full_name>Hyung-Ho Kim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
    <mesh_term>Dumping Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is currently no plan to share our IPD with other researchers unless needed.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

